Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-31

Clinical Trial Update: Effects on Crying Time in Colicky Infants With the Supplementation of Lactobacillus Reuteri DSM 17938 [NA]

View source ↗

Summary

An update on a clinical trial examining whether Lactobacillus reuteri DSM 17938 reduces crying time in colicky infants. The sponsor is Shanghai Children's Hospi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: Shanghai Children's Hospital | Conditions: Crying Time in Colicky Infants | NA | Status: UNKNOWN